nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—CCND1—eye—Graves' disease	0.0184	0.0448	CbGeAlD
Arsenic trioxide—CCND1—connective tissue—Graves' disease	0.0178	0.0432	CbGeAlD
Arsenic trioxide—MAPK1—eye—Graves' disease	0.0155	0.0378	CbGeAlD
Arsenic trioxide—MAPK1—connective tissue—Graves' disease	0.015	0.0364	CbGeAlD
Arsenic trioxide—TXNRD1—eye—Graves' disease	0.0144	0.0352	CbGeAlD
Arsenic trioxide—TXNRD1—connective tissue—Graves' disease	0.0139	0.0339	CbGeAlD
Arsenic trioxide—MAPK3—eye—Graves' disease	0.0137	0.0334	CbGeAlD
Arsenic trioxide—CCND1—pituitary gland—Graves' disease	0.0137	0.0333	CbGeAlD
Arsenic trioxide—CCND1—adipose tissue—Graves' disease	0.0136	0.0331	CbGeAlD
Arsenic trioxide—MAPK3—connective tissue—Graves' disease	0.0132	0.0322	CbGeAlD
Arsenic trioxide—AKT1—eye—Graves' disease	0.013	0.0315	CbGeAlD
Arsenic trioxide—AKT1—connective tissue—Graves' disease	0.0125	0.0304	CbGeAlD
Arsenic trioxide—CCND1—thyroid gland—Graves' disease	0.0118	0.0287	CbGeAlD
Arsenic trioxide—MAPK1—adipose tissue—Graves' disease	0.0115	0.0279	CbGeAlD
Arsenic trioxide—JUN—eye—Graves' disease	0.0113	0.0274	CbGeAlD
Arsenic trioxide—JUN—connective tissue—Graves' disease	0.0109	0.0264	CbGeAlD
Arsenic trioxide—IKBKB—connective tissue—Graves' disease	0.0108	0.0263	CbGeAlD
Arsenic trioxide—TXNRD1—pituitary gland—Graves' disease	0.0107	0.0261	CbGeAlD
Arsenic trioxide—TXNRD1—adipose tissue—Graves' disease	0.0107	0.026	CbGeAlD
Arsenic trioxide—MAPK3—pituitary gland—Graves' disease	0.0102	0.0248	CbGeAlD
Arsenic trioxide—MAPK3—adipose tissue—Graves' disease	0.0102	0.0247	CbGeAlD
Arsenic trioxide—MAPK1—thyroid gland—Graves' disease	0.00993	0.0242	CbGeAlD
Arsenic trioxide—AKT1—pituitary gland—Graves' disease	0.00962	0.0234	CbGeAlD
Arsenic trioxide—AKT1—adipose tissue—Graves' disease	0.00958	0.0233	CbGeAlD
Arsenic trioxide—TXNRD1—thyroid gland—Graves' disease	0.00925	0.0225	CbGeAlD
Arsenic trioxide—MAPK3—thyroid gland—Graves' disease	0.00879	0.0214	CbGeAlD
Arsenic trioxide—JUN—pituitary gland—Graves' disease	0.00837	0.0204	CbGeAlD
Arsenic trioxide—JUN—adipose tissue—Graves' disease	0.00834	0.0203	CbGeAlD
Arsenic trioxide—IKBKB—pituitary gland—Graves' disease	0.00833	0.0203	CbGeAlD
Arsenic trioxide—IKBKB—adipose tissue—Graves' disease	0.0083	0.0202	CbGeAlD
Arsenic trioxide—AKT1—thyroid gland—Graves' disease	0.00829	0.0202	CbGeAlD
Arsenic trioxide—JUN—thyroid gland—Graves' disease	0.00722	0.0176	CbGeAlD
Arsenic trioxide—IKBKB—thyroid gland—Graves' disease	0.00718	0.0175	CbGeAlD
Arsenic trioxide—CYP1B1—eye—Graves' disease	0.00601	0.0146	CbGeAlD
Arsenic trioxide—CYP1B1—connective tissue—Graves' disease	0.00579	0.0141	CbGeAlD
Arsenic trioxide—CYP1B1—pituitary gland—Graves' disease	0.00446	0.0109	CbGeAlD
Arsenic trioxide—CYP1B1—adipose tissue—Graves' disease	0.00444	0.0108	CbGeAlD
Arsenic trioxide—CYP1B1—thyroid gland—Graves' disease	0.00385	0.00936	CbGeAlD
Arsenic trioxide—CYP1A1—adipose tissue—Graves' disease	0.00314	0.00764	CbGeAlD
Arsenic trioxide—CYP1A1—thyroid gland—Graves' disease	0.00272	0.00662	CbGeAlD
Arsenic trioxide—ABCB1—pituitary gland—Graves' disease	0.00164	0.00399	CbGeAlD
Arsenic trioxide—ABCB1—adipose tissue—Graves' disease	0.00163	0.00397	CbGeAlD
Arsenic trioxide—ABCB1—thyroid gland—Graves' disease	0.00141	0.00344	CbGeAlD
Arsenic trioxide—AKT1—Apoptosis—TNF—Graves' disease	0.000533	0.000905	CbGpPWpGaD
Arsenic trioxide—MAPK1—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000531	0.000902	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by Interleukins—IL1B—Graves' disease	0.00053	0.000901	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—HLA-A—Graves' disease	0.00053	0.0009	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—IFIH1—Graves' disease	0.000529	0.000899	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.000522	0.000887	CbGpPWpGaD
Arsenic trioxide—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000517	0.000878	CbGpPWpGaD
Arsenic trioxide—MAPK1—Alzheimers Disease—TNF—Graves' disease	0.000517	0.000877	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—IL1B—Graves' disease	0.000517	0.000877	CbGpPWpGaD
Arsenic trioxide—JUN—TNF alpha Signaling Pathway—TNF—Graves' disease	0.000516	0.000876	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000511	0.000868	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—IFIH1—Graves' disease	0.000509	0.000863	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.0005	0.000849	CbGpPWpGaD
Arsenic trioxide—AKT1—TNF alpha Signaling Pathway—TNF—Graves' disease	0.000496	0.000841	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—IFIH1—Graves' disease	0.000493	0.000838	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000493	0.000837	CbGpPWpGaD
Arsenic trioxide—MAPK1—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000492	0.000835	CbGpPWpGaD
Arsenic trioxide—AKT1—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000491	0.000834	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	0.000484	0.000822	CbGpPWpGaD
Arsenic trioxide—MAPK3—TNF alpha Signaling Pathway—TNF—Graves' disease	0.000481	0.000816	CbGpPWpGaD
Arsenic trioxide—MAPK3—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000476	0.000808	CbGpPWpGaD
Arsenic trioxide—JUN—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000475	0.000806	CbGpPWpGaD
Arsenic trioxide—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000471	0.000799	CbGpPWpGaD
Arsenic trioxide—IKBKB—Apoptosis—TNF—Graves' disease	0.000471	0.000799	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—IFIH1—Graves' disease	0.000469	0.000797	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000469	0.000797	CbGpPWpGaD
Arsenic trioxide—JUN—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	0.000468	0.000795	CbGpPWpGaD
Arsenic trioxide—JUN—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000466	0.000791	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000462	0.000785	CbGpPWpGaD
Arsenic trioxide—MAPK1—TNF alpha Signaling Pathway—TNF—Graves' disease	0.000457	0.000777	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000457	0.000776	CbGpPWpGaD
Arsenic trioxide—MAPK3—Interferon Signaling—IFNG—Graves' disease	0.000457	0.000775	CbGpPWpGaD
Arsenic trioxide—AKT1—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000456	0.000775	CbGpPWpGaD
Arsenic trioxide—MAPK1—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000453	0.000769	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—IFIH1—Graves' disease	0.000449	0.000762	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000449	0.000762	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000446	0.000757	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TSHR—Graves' disease	0.000444	0.000753	CbGpPWpGaD
Arsenic trioxide—MAPK3—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000443	0.000751	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000442	0.00075	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000442	0.00075	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.00044	0.000746	CbGpPWpGaD
Arsenic trioxide—JUN—MAPK Signaling Pathway—IL1B—Graves' disease	0.000439	0.000746	CbGpPWpGaD
Arsenic trioxide—IKBKB—TNF alpha Signaling Pathway—TNF—Graves' disease	0.000438	0.000743	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000435	0.000738	CbGpPWpGaD
Arsenic trioxide—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000433	0.000736	CbGpPWpGaD
Arsenic trioxide—AKT1—MAPK Signaling Pathway—IL1B—Graves' disease	0.000422	0.000716	CbGpPWpGaD
Arsenic trioxide—MAPK1—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000421	0.000715	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000421	0.000714	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000417	0.000709	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—HLA-E—Graves' disease	0.000416	0.000707	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000416	0.000706	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—IL1B—Graves' disease	0.000409	0.000695	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000403	0.000684	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000401	0.00068	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—HLA-E—Graves' disease	0.0004	0.000679	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000397	0.000674	CbGpPWpGaD
Arsenic trioxide—MAPK3—Spinal Cord Injury—TNF—Graves' disease	0.000394	0.000669	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—IL1B—Graves' disease	0.000389	0.000661	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—HLA-E—Graves' disease	0.000388	0.000659	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GC—Graves' disease	0.000388	0.000659	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HLA-E—Graves' disease	0.000384	0.000652	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000381	0.000647	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.00038	0.000645	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—TSHR—Graves' disease	0.00038	0.000645	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD40—Graves' disease	0.000376	0.000638	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—TNF—Graves' disease	0.000375	0.000636	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—IL1B—Graves' disease	0.000373	0.000632	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000371	0.00063	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CTLA4—Graves' disease	0.00037	0.000628	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—HLA-E—Graves' disease	0.000369	0.000627	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000365	0.000619	CbGpPWpGaD
Arsenic trioxide—AKT1—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000356	0.000605	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—IFNG—Graves' disease	0.000354	0.0006	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—HLA-E—Graves' disease	0.000353	0.0006	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—B3GNT2—Graves' disease	0.000351	0.000596	CbGpPWpGaD
Arsenic trioxide—MAPK3—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000346	0.000587	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—TSHR—Graves' disease	0.000345	0.000585	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—B3GNT2—Graves' disease	0.00034	0.000578	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-E—Graves' disease	0.000339	0.000576	CbGpPWpGaD
Arsenic trioxide—JUN—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000338	0.000574	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—TSHR—Graves' disease	0.000334	0.000568	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD40—Graves' disease	0.000332	0.000563	CbGpPWpGaD
Arsenic trioxide—MAPK1—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000329	0.000558	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CTLA4—Graves' disease	0.000327	0.000555	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—TNF—Graves' disease	0.000327	0.000554	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—B3GNT2—Graves' disease	0.000324	0.00055	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GC—Graves' disease	0.000322	0.000547	CbGpPWpGaD
Arsenic trioxide—JUN—MAPK Signaling Pathway—TNF—Graves' disease	0.000319	0.000541	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—TSHR—Graves' disease	0.000318	0.00054	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—IL1B—Graves' disease	0.000315	0.000536	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000315	0.000535	CbGpPWpGaD
Arsenic trioxide—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000315	0.000534	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IFIH1—Graves' disease	0.000308	0.000523	CbGpPWpGaD
Arsenic trioxide—AKT1—MAPK Signaling Pathway—TNF—Graves' disease	0.000306	0.00052	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000305	0.000518	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000305	0.000517	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—TNF—Graves' disease	0.000297	0.000504	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—IL2RA—Graves' disease	0.000297	0.000504	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—HLA-B—Graves' disease	0.000297	0.000504	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IFIH1—Graves' disease	0.000296	0.000503	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—B3GNT2—Graves' disease	0.000294	0.000499	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.00029	0.000492	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—IL2RA—Graves' disease	0.000288	0.000489	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000288	0.000488	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IFIH1—Graves' disease	0.000287	0.000488	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CXCL10—Graves' disease	0.000287	0.000487	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—HLA-B—Graves' disease	0.000285	0.000484	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD8A—Graves' disease	0.000285	0.000483	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—TNF—Graves' disease	0.000283	0.00048	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000278	0.000471	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—HLA-B—Graves' disease	0.000277	0.000469	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000276	0.000469	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000276	0.000468	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—IL2RA—Graves' disease	0.000274	0.000465	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HLA-B—Graves' disease	0.000274	0.000465	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IFIH1—Graves' disease	0.000273	0.000464	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000272	0.000462	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—TNF—Graves' disease	0.00027	0.000459	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000269	0.000457	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000268	0.000455	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000266	0.000452	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—HLA-B—Graves' disease	0.000263	0.000447	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IFIH1—Graves' disease	0.000262	0.000444	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000259	0.000439	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000255	0.000433	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HLA-A—Graves' disease	0.000254	0.000431	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—HLA-B—Graves' disease	0.000252	0.000427	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD8A—Graves' disease	0.000251	0.000427	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000248	0.00042	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—CXCL10—Graves' disease	0.000245	0.000417	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—B3GNT2—Graves' disease	0.000244	0.000415	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-E—Graves' disease	0.000243	0.000412	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-B—Graves' disease	0.000242	0.00041	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD40—Graves' disease	0.000237	0.000403	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CTLA4—Graves' disease	0.000234	0.000397	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-E—Graves' disease	0.000233	0.000396	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000232	0.000393	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—TNF—Graves' disease	0.000229	0.000389	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD40—Graves' disease	0.000228	0.000387	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-E—Graves' disease	0.000226	0.000384	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CTLA4—Graves' disease	0.000224	0.000381	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-A—Graves' disease	0.000224	0.00038	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CXCL10—Graves' disease	0.000223	0.000378	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—ICAM1—Graves' disease	0.000222	0.000378	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD40—Graves' disease	0.000221	0.000375	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL2RA—Graves' disease	0.000219	0.000372	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CTLA4—Graves' disease	0.000218	0.00037	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CXCL10—Graves' disease	0.000216	0.000367	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-E—Graves' disease	0.000215	0.000365	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TSHR—Graves' disease	0.000212	0.00036	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD40—Graves' disease	0.00021	0.000357	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CTLA4—Graves' disease	0.000207	0.000352	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-E—Graves' disease	0.000206	0.000349	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CXCL10—Graves' disease	0.000206	0.000349	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000205	0.000347	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TSHR—Graves' disease	0.000204	0.000346	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD40—Graves' disease	0.000201	0.000341	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GC—Graves' disease	0.000199	0.000337	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CTLA4—Graves' disease	0.000198	0.000337	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TSHR—Graves' disease	0.000198	0.000335	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—ICAM1—Graves' disease	0.000196	0.000333	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-DQB1—Graves' disease	0.000192	0.000327	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TSHR—Graves' disease	0.000188	0.000319	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—IL2RA—Graves' disease	0.000188	0.000318	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-DQB1—Graves' disease	0.000185	0.000314	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TSHR—Graves' disease	0.00018	0.000305	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD8A—Graves' disease	0.00018	0.000305	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-DQB1—Graves' disease	0.000179	0.000304	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CD4—Graves' disease	0.000177	0.000301	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-B—Graves' disease	0.000173	0.000293	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD8A—Graves' disease	0.000173	0.000293	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-DQB1—Graves' disease	0.000171	0.00029	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL2RA—Graves' disease	0.00017	0.000289	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CD4—Graves' disease	0.00017	0.000289	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD8A—Graves' disease	0.000167	0.000284	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-B—Graves' disease	0.000166	0.000282	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL2RA—Graves' disease	0.000165	0.00028	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CD4—Graves' disease	0.000165	0.00028	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD4—Graves' disease	0.000163	0.000278	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-DQB1—Graves' disease	0.000163	0.000277	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL2RA—Graves' disease	0.000162	0.000275	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-B—Graves' disease	0.000161	0.000273	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-A—Graves' disease	0.00016	0.000272	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD8A—Graves' disease	0.000159	0.00027	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GC—Graves' disease	0.000159	0.000269	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL2RA—Graves' disease	0.000157	0.000267	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CD4—Graves' disease	0.000157	0.000267	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL2RA—Graves' disease	0.000156	0.000264	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-A—Graves' disease	0.000154	0.000261	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-B—Graves' disease	0.000153	0.00026	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD8A—Graves' disease	0.000152	0.000259	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL2RA—Graves' disease	0.000151	0.000256	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—B3GNT2—Graves' disease	0.000151	0.000256	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CD4—Graves' disease	0.00015	0.000255	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-A—Graves' disease	0.000149	0.000253	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-B—Graves' disease	0.000147	0.000249	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-DRB1—Graves' disease	0.000146	0.000248	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD4—Graves' disease	0.000144	0.000245	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL2RA—Graves' disease	0.000144	0.000244	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—HLA-A—Graves' disease	0.000142	0.000241	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-A—Graves' disease	0.000142	0.000241	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-DRB1—Graves' disease	0.000141	0.000239	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—ICAM1—Graves' disease	0.00014	0.000238	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—HLA-A—Graves' disease	0.000138	0.000234	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL2RA—Graves' disease	0.000137	0.000233	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CXCL10—Graves' disease	0.000137	0.000233	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-DRB1—Graves' disease	0.000136	0.000231	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-A—Graves' disease	0.000136	0.000231	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—ICAM1—Graves' disease	0.000135	0.000229	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCL10—Graves' disease	0.000132	0.000223	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HLA-A—Graves' disease	0.000131	0.000223	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—ICAM1—Graves' disease	0.000131	0.000222	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-DRB1—Graves' disease	0.00013	0.00022	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—Graves' disease	0.000129	0.000219	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCL10—Graves' disease	0.000128	0.000217	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—Graves' disease	0.000125	0.000213	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—ICAM1—Graves' disease	0.000125	0.000211	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-DRB1—Graves' disease	0.000124	0.000211	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCL10—Graves' disease	0.000121	0.000206	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—B3GNT2—Graves' disease	0.00012	0.000204	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—Graves' disease	0.000119	0.000202	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ICAM1—Graves' disease	0.000119	0.000202	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCL10—Graves' disease	0.000116	0.000197	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000113	0.000192	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IFNG—Graves' disease	0.000107	0.000181	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL2RA—Graves' disease	0.000105	0.000178	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD4—Graves' disease	0.000103	0.000175	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IFNG—Graves' disease	0.000103	0.000174	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL2RA—Graves' disease	0.000101	0.000171	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IFNG—Graves' disease	9.96e-05	0.000169	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD4—Graves' disease	9.92e-05	0.000168	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GC—Graves' disease	9.77e-05	0.000166	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL2RA—Graves' disease	9.76e-05	0.000166	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD4—Graves' disease	9.62e-05	0.000163	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1B—Graves' disease	9.53e-05	0.000162	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IFNG—Graves' disease	9.47e-05	0.000161	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL2RA—Graves' disease	9.28e-05	0.000158	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1B—Graves' disease	9.16e-05	0.000155	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CD4—Graves' disease	9.15e-05	0.000155	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD4—Graves' disease	9.15e-05	0.000155	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IFNG—Graves' disease	9.06e-05	0.000154	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL2RA—Graves' disease	8.88e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1B—Graves' disease	8.88e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CD4—Graves' disease	8.88e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD4—Graves' disease	8.75e-05	0.000149	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1B—Graves' disease	8.45e-05	0.000143	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CD4—Graves' disease	8.45e-05	0.000143	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1B—Graves' disease	8.09e-05	0.000137	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—B3GNT2—Graves' disease	7.41e-05	0.000126	CbGpPWpGaD
